Rating Change
BMO Capital reiterated its Market Perform rating on Amgen Inc. (NASDAQ:AMGN) on October 12, 2026.
reiterateNASDAQ:AMGN
BMO Capital Reiterates Market Perform Rating on Amgen Inc. (AMGN)
BMO Capital reiterated its Market Perform rating on Amgen Inc. (NASDAQ:AMGN) on October 12, 2026.
At publication ·
What changed
Amgen Inc. (NASDAQ:AMGN) · reiterate
- Firm
- BMO Capital
- Rating
- Market Perform to Market Perform
- Price at event
- $417.57
- Market capitalization
- $209.2B
At a glance
Key takeaways
- BMO Capital maintained its Market Perform rating on Amgen on October 12, 2026, indicating neutral sentiment toward the stock.
Market Context
Amgen Inc. operates in the Healthcare sector. The stock currently trades at $417.57 with a market capitalization of $209.2B. The stock has gained 24.2% over the past 52 weeks.
Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Amgen Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Amgen Inc.
Among the 10 most recent ratings: 3 Buy, 7 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | Wells Fargo | Equal-Weight | N/A |
| Oct 12, 2026 | BMO Capital | Market Perform | N/A |
| Oct 09, 2026 | UBS | Buy | N/A |
| Oct 08, 2026 | RBC Capital | Outperform | N/A |
| Oct 08, 2026 | Cantor Fitzgerald | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View AMGN Stock Page
Frequently Asked Questions
What does the Market Perform rating mean for AMGN?
A rating of Market Perform from BMO Capital reflects the analyst's outlook on Amgen Inc. (NASDAQ:AMGN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AMGN forecast page.